Our developmental pipeline enables results from discovery to clinical implementation. From companion diagnostic (CDx) co-development to precision streamlined development and implementation of assays and diagnostic tests, we are here to help support your unique clinical trial and project objectives.
Clinical trial support, biomarker discovery, biomarker validation, translation of tissue markers to plasma, companion diagnostic development
Leveraging the power of DNA, RNA, and Protein data from Extracellular Vesicles for comprehensive multiomics insights of biology and disease
Extracellular Vesicle-focused company with extensive experience in EVs and their various applications to understand diseases with unmet clinical needs
Our expertise in Extracellular Vesicles (EVs) and operations in a CLIA-certified lab enable us to tackle challenges that organizations have when developing or deploying a therapy. Aware of various factors contributing to trial failures, such as the critical issue of unsuitable patient selection, we employ our multiomics workflows and comprehensive understanding of disease pathways and drug interactions. Partnering with FYR has the potential to increase trial success rates and yield more accurate outcomes, with our team’s experience and EV technologies driving research objectives and clinical strategy optimization.
Have we sparked your interest in partnering with us? We fuel new relationships, collaborations, and strategic partnerships. Let’s kindle the next generation of innovation together. To learn more about our services or to receive a quote, contact us.